RESEARCH TRIANGLE PARK, NC – Imagine being able to know, definitively, if you were going to get diabetes.
Study results mean Research Triangle Park-based diagnostic firm Metabolon could one day make that a reality, starting with its new Type 2 diabetes test which enables the patient to prepare and get ahead of the disease.
Studies show the pre-diabetes blood test, dubbed Quantose, identifies individuals at risk for the condition earlier and more accurately than just by measuring traditional risk factors. The test outperformed traditional risk measures such as fasting insulin and fasting glucose in predicting insulin resistance and progression into impaired glucose tolerance.
“These studies are clear affirmation of Quantose’s value to predict early those individuals at risk for eventual onset of Type 2 diabetes which may provide clinicians the opportunity for treatment interventions that may reverse the prediabetic state,” says Eric Button, senior vice president of diagnostics.